AWS Startups Blog
Author: Boris Oklander
Boris Oklander, co-founder and CTO of C2i Genomics, has driven the company's technological evolution and successfully secured over $100m in funding. With a career exceeding 20 years, his experience includes CTO roles in defense and AI-based diagnostics, along with developing mission-critical systems as an R&D Officer in the IDF. Oklander earned his Ph.D. in Electrical Engineering from the Technion and undertook a post-doctoral research position in cognitive systems at Imperial College London. His professional achievements are reflected in various patents and publications.
How C2i Genomics builds on AWS to transform cancer care
Healthcare and life sciences (HCLS) startups recognize that technology is an impactful vehicle for advancing human health at speed and scale. More importantly, HCLS startups are working to do something about it. C2i Genomics, founded in 2019, is one such startup: C2i Genomics is building a whole genome intelligence platform to improve cancer monitoring. Using artificial intelligence (AI) and machine learning (ML) solutions, C2i Genomics’ platform analyzes sequenced genome data to detect the tumor burden of cancer patients via a simple blood test.